EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Population Pharmacokinetics of Dolutegravir in African Children: Results From the CHAPAS-4 Trial

Hylke Waalewijn, Roeland E Wasmann iD, Alasdair Bamford, Diana M Gibb, Helen M McIlleron iD, Angela Colbers iD, David M Burger, Paolo Denti iD, CHAPAS-4 trial team

Journal of the Pediatric Infectious Diseases Society · 2024

DOI: 10.1093/jpids/piae076 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, 2024. Verfasst von Hylke Waalewijn und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa. Hauptthemen laut MEDLINE: Pyridones, Heterocyclic Compounds, 3-Ring, Oxazines, Piperazines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European and Developing Countries Clinical Trials Partnership, Janssen Pharmaceuticals and Gilead Sciences Inc, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We characterized population pharmacokinetics in 42 African children receiving once-daily 25 mg (14 to <20 kg) or 50 mg (>20 kg) dolutegravir. Coadministration with emtricitabine and tenofovir alafenamide reduced dolutegravir bioavailability by 19.6% (95% confidence interval: 8.13%–30.8%) compared with zidovudine or abacavir with lamivudine. Nevertheless, concentrations remained above efficacy targets, confirming current dosing recommendations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyridonesHeterocyclic Compounds, 3-RingOxazinesPiperazinesHIV InfectionsAnti-HIV AgentsHumansChildMaleFemaleTenofovirChild, PreschoolAdolescentEmtricitabineDideoxynucleosidesLamivudineHIV Integrase InhibitorsAlanineBiological AvailabilityDrug Therapy, CombinationZidovudineAdenineDrug InteractionsDolutegravir

Stichwörter der Autor:innen

HIVchildrendolutegravirpharmacokineticpopulation pharmacokinetics

Substanzen

PyridonesHeterocyclic Compounds, 3-RingOxazinesPiperazinesAnti-HIV AgentsTenofovirEmtricitabineDideoxynucleosidesLamivudineHIV Integrase Inhibitors

Autor:innen und Institutionen

  • Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Medical Research Council Clinical Trials Unit, University College London, London, UK.
  • Infection, Immunity & Inflammation Department, UCL Great Ormond Street Hospital Institute of Child Health, London, UK.
  • Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

ORCID-Profile: Roeland E Wasmann, Helen M McIlleron, Angela Colbers, Paolo Denti

Förderung

  • European and Developing Countries Clinical Trials Partnership
  • Janssen Pharmaceuticals and Gilead Sciences Inc
  • NIAID NIH HHS
  • South African National Institute of Allergy and Infectious Diseases (NIAID) of the South African National Institutes of Health

Zitieren

APA

Waalewijn, H., Wasmann, R. E., Bamford, A., Gibb, D. M., McIlleron, H. M., Colbers, A., Burger, D. M., Denti, P., & CHAPAS-4 trial team (2024). Population Pharmacokinetics of Dolutegravir in African Children: Results From the CHAPAS-4 Trial. Journal of the Pediatric Infectious Diseases Society. https://doi.org/10.1093/jpids/piae076

Vancouver

Waalewijn H, Wasmann RE, Bamford A, Gibb DM, McIlleron HM, Colbers A, et al. Population Pharmacokinetics of Dolutegravir in African Children: Results From the CHAPAS-4 Trial. Journal of the Pediatric Infectious Diseases Society. 2024. doi:10.1093/jpids/piae076

BibTeX
@article{Waalewijn2024,
  author = {Waalewijn, Hylke and Wasmann, Roeland E and Bamford, Alasdair and Gibb, Diana M and McIlleron, Helen M and Colbers, Angela and Burger, David M and Denti, Paolo and CHAPAS-4 trial team, CHAPAS-4 trial team},
  title = {Population Pharmacokinetics of Dolutegravir in African Children: Results From the CHAPAS-4 Trial},
  journal = {Journal of the Pediatric Infectious Diseases Society},
  year = {2024},
  doi = {10.1093/jpids/piae076}
}
Kostenlos starten →